RESUMO
Coffee consumption has been reported to reduce the risk of type 2 diabetes in experimental and epidemiological studies. This anti-diabetic effect of coffee may be attributed to its high content in polyphenols especially caffeic acid and chlorogenic acid. However, the association between plasma coffee polyphenols and diabetic risks has never been investigated in the literature. In this study, fasting plasma samples were collected from 57 generally healthy females aged 38-73 (mean 52, s.d. 8) years recruited in Himeji, Japan. The concentrations of plasma coffee polyphenols were determined by liquid chromatography coupled with mass tandem spectrometer. Diabetes biomarkers in the plasma/serum samples were analysed by a commercial diagnostic laboratory. Statistical associations were assessed using Spearman's correlation coefficients. The results showed that plasma chlorogenic acid exhibited negative associations with fasting blood glucose, glycated hemoglobin and C-reactive protein, whereas plasma total coffee polyphenol and plasma caffeic acid were weakly associated with these biomarkers. Our preliminary data support previous findings that coffee polyphenols have anti-diabetic effects but further replications with large samples of both genders are recommended.
Assuntos
Biomarcadores/sangue , Ácidos Cafeicos/sangue , Ácido Clorogênico/sangue , Café , Diabetes Mellitus Tipo 2/prevenção & controle , Adulto , Idoso , Proteína C-Reativa , Café/química , Feminino , Hemoglobinas Glicadas/análise , Humanos , Pessoa de Meia-Idade , RiscoRESUMO
Application of a gamma mixture model to obstetrical diagnosis-related groups (DRGs) revealed heterogeneity of maternity length of stay (LOS). The proportion of long-stay subgroups identified, which can account for 30% of admissions, varied between DRGs. The burden of long-stay patients borne was estimated to be much higher in private hospitals than public hospitals for normal delivery, but vice versa for Caesarean section. Such differences highlights the impact of DRG-based casemix funding on inpatient LOS and have significant implications for health insurance companies to integrate casemix funding across the public and private sectors. The analysis also benefits hospital administrators and managers to budget expenditures accordingly.
Assuntos
Grupos Diagnósticos Relacionados/estatística & dados numéricos , Hospitais Privados/estatística & dados numéricos , Hospitais Públicos/estatística & dados numéricos , Tempo de Internação/estatística & dados numéricos , Serviços de Saúde Materna/organização & administração , Complicações na Gravidez/classificação , Feminino , Pesquisa sobre Serviços de Saúde , Humanos , Serviços de Saúde Materna/estatística & dados numéricos , Modelos Estatísticos , Programas Nacionais de Saúde , Gravidez , Complicações na Gravidez/epidemiologia , Austrália Ocidental/epidemiologiaRESUMO
The gene encoding a red-shifted green fluorescent protein variant (EGFP) was introduced into a human immunodeficiency virus type 1 (HIV-1) molecular clone by replacing the nef gene. The EGFP-expressing HIV-1 replicated efficiently in established human T cells. The expression of EGFP in the virus-infected cells was confirmed by fluorescence microscopy and also by Western blot analysis using the GFP antibodies. The EGFP gene was stably maintained in the viral genome during prolonged passages. EGFP-expressing HIV-1 could be used for anti-HIV-1 drug screening, sorting of virus-infected cells by fluorescence activated cell sorting (FACS) analysis, and for the rapid and simple detection of virus-infected cells by fluorescence microscopy.